Gilead Sciences Inc. et al. v. Canada (Minister of Health), 2016 FC 231
| Judge | Heneghan, J. |
| Court | Federal Court (Canada) |
| Case Date | March 08, 2016 |
| Jurisdiction | Canada (Federal) |
| Citations | 2016 FC 231 |
-
- This document is available in original version only for vLex customers
View this document and try vLex for 7 days - TRY VLEX
- This document is available in original version only for vLex customers
5 practice notes
-
Gilead Sciences, Inc. v. Canada (Health), 2016 FC 856
...ineligible for listing on the Patent Registry, and therefore ineligible for NOC proceedings in Gilead Sciences, Inc v Canada (Health), 2016 FC 231. As a result the 619 Patent was also struck from this proceeding. The Federal Court of Appeal dismissed an appeal from that decision: Gilead Sci......
-
Gilead Sciences Inc. et al. v. Canada (Minister of Health) et al., 2016 FC 857
...for listing on the Patent Register and therefore ineligible for inclusion in that proceeding: Gilead Sciences, Inc v Canada (Health), 2016 FC 231; the 619 Patent was therefore struck from the Patent Register for purposes of that court file. An appeal was dismissed by the Federal Court of Ap......
-
Allegations Against Canadian Tenofovir Patent Found Unjustified (Again)
...FC 1271; Gilead Sciences, Inc. et al. v. Teva Canada Limited et al., 2013 FC 1272, Gilead Sciences, Inc. et al. v. Apotex, Inc. et al., 2016 FC 231; aff'd 2016 FCA To view the original article please click here. The content of this article is intended to provide a general guide to the subje......
-
Old Law Continues To Frustrate Innovator Protections For Combo-Drugs In Canada
...protections for combination drug products. On March 8, 2016, the Federal Court surprisingly granted a summary motion in Gilead v Apotex, 2016 FC 231, which was brought by Apotex in the context of a PM(NOC) case over Gilead's combination drug product TRUVADA®. Apotex sought and was granted a......
Request a trial to view additional results
2 cases
-
Gilead Sciences, Inc. v. Canada (Health), 2016 FC 856
...ineligible for listing on the Patent Registry, and therefore ineligible for NOC proceedings in Gilead Sciences, Inc v Canada (Health), 2016 FC 231. As a result the 619 Patent was also struck from this proceeding. The Federal Court of Appeal dismissed an appeal from that decision: Gilead Sci......
-
Gilead Sciences Inc. et al. v. Canada (Minister of Health) et al., 2016 FC 857
...for listing on the Patent Register and therefore ineligible for inclusion in that proceeding: Gilead Sciences, Inc v Canada (Health), 2016 FC 231; the 619 Patent was therefore struck from the Patent Register for purposes of that court file. An appeal was dismissed by the Federal Court of Ap......
3 firm's commentaries
-
Allegations Against Canadian Tenofovir Patent Found Unjustified (Again)
...FC 1271; Gilead Sciences, Inc. et al. v. Teva Canada Limited et al., 2013 FC 1272, Gilead Sciences, Inc. et al. v. Apotex, Inc. et al., 2016 FC 231; aff'd 2016 FCA To view the original article please click here. The content of this article is intended to provide a general guide to the subje......
-
Old Law Continues To Frustrate Innovator Protections For Combo-Drugs In Canada
...protections for combination drug products. On March 8, 2016, the Federal Court surprisingly granted a summary motion in Gilead v Apotex, 2016 FC 231, which was brought by Apotex in the context of a PM(NOC) case over Gilead's combination drug product TRUVADA®. Apotex sought and was granted a......
-
Motion Challenging The Listing Of A Patent On The Patent Register Filed Before The 2015 Amendments To The PM(NOC) Regulations Is Decided On The Basis Of The Old Regulations (Intellectual Property Weekly Abstracts Bulletin Week Of March 14)
...the 2015 amendments to the PM(NOC) Regulations is decided on the basis of the old regulations Gilead Sciences, Inc. v. Canada (Health), 2016 FC 231 Apotex has successfully challenged the listing of a patent on the Patent Register pursuant to paragraph 4(2)(a) of the PM(NOC) The patent does ......